Insights into the Potential Dual-antibacterial Mechanism of Kelisha Capsule on Escherichia Coli

Overview

Journal BMC Complement Med Ther

Publisher Biomed Central

Specialty Rehabilitation Medicine

Date 2024 May 28

PMID 38807130

Authors

Guolin Shi

Xiao Lu

Yuanhang Zheng

Tao Yang

Enyuan Zhu

Yanhong Song

Pintong Huang

Affiliations

Soon will be listed here.

Abstract

Traditional Chinese medicine (TCM), AYURVEDA and Indian medicine are essential in disease prevention and treatment. Kelisha capsule (KLSC), a TCM formula listed in the Chinese Pharmacopoeia, has been clinically proven to possess potent antibacterial properties. However, the precise antimicrobial mechanism of KLSC remained unknown. This study aimed to elucidate the dual antibacterial mechanism of KLSC using network pharmacology, molecular docking, and experimental validation. By analyzing the growth curve of Escherichia coli (E. coli), it was observed that KLSC significantly inhibited its growth, showcasing a remarkable antibacterial effect. Furthermore, SEM and TEM analysis revealed that KLSC damaged the cell wall and membrane of E. coli, resulting in cytoplasmic leakage, bacterial death, and the exertion of antibacterial effects. The network pharmacology analysis revealed that KLSC exhibited an effect on E. coli ATP synthase, thereby influencing the energy metabolism process. The molecular docking outcomes provided evidence that the active compounds of KLSC could effectively bind to the ATP synthase subunit. Subsequently, experimental findings substantiated that KLSC effectively suppressed the activity of ATP synthase in E. coli and consequently decreased the ATP content. This study highlighted the dual antibacterial mechanism of KLSC, emphasizing its effects on cell structure and energy metabolism, suggesting its potential as a natural antibacterial agent for E. coli-related infections. These findings offered new insights into exploring the antibacterial mechanisms of TCM by focusing on the energy metabolism process.

References

Issa D, Najjar A, Greige-Gerges H, Nehme H . Screening of Some Essential Oil Constituents as Potential Inhibitors of the ATP Synthase of Escherichia coli. J Food Sci. 2018; 84(1):138-146. DOI: 10.1111/1750-3841.14421. View

Li X, Wei S, Niu S, Ma X, Li H, Jing M . Network pharmacology prediction and molecular docking-based strategy to explore the potential mechanism of Huanglian Jiedu Decoction against sepsis. Comput Biol Med. 2022; 144:105389. DOI: 10.1016/j.compbiomed.2022.105389. View

Li W, Xie X, Shi Q, Zeng H, Ou-Yang Y, Chen Y . Antibacterial activity and mechanism of silver nanoparticles on Escherichia coli. Appl Microbiol Biotechnol. 2009; 85(4):1115-22. DOI: 10.1007/s00253-009-2159-5. View

Mehta J, Utkarsh K, Fuloria S, Singh T, Sekar M, Salaria D . Antibacterial Potential of (L.) Wettst. and Its Bioactive Molecules against Uropathogens-An In Silico Study to Identify Potential Lead Molecule(s) for the Development of New Drugs to Treat Urinary Tract Infections. Molecules. 2022; 27(15). PMC: 9370325. DOI: 10.3390/molecules27154971. View

Liu B, Zhou C, Zhang Z, Roland J, Lee B . Antimicrobial Property of Halogenated Catechols. Chem Eng J. 2020; 403. PMC: 7444726. DOI: 10.1016/j.cej.2020.126340. View

Yang Y, Zhou X, Jia G, Li T, Li Y, Zhao R . Network pharmacology based research into the effect and potential mechanism of Portulaca oleracea L. polysaccharide against ulcerative colitis. Comput Biol Med. 2023; 161:106999. DOI: 10.1016/j.compbiomed.2023.106999. View

Sharma A, Flores-Vallejo R, Cardoso-Taketa A, Villarreal M . Antibacterial activities of medicinal plants used in Mexican traditional medicine. J Ethnopharmacol. 2016; 208:264-329. DOI: 10.1016/j.jep.2016.04.045. View

Shen X, Zhang W, Peng C, Yan J, Chen P, Jiang C . In vitro anti-bacterial activity and network pharmacology analysis of Sanguisorba officinalis L. against Helicobacter pylori infection. Chin Med. 2021; 16(1):33. PMC: 8052767. DOI: 10.1186/s13020-021-00442-1. View

Welsh M, Taguchi A, Schaefer K, Van Tyne D, Lebreton F, Gilmore M . Identification of a Functionally Unique Family of Penicillin-Binding Proteins. J Am Chem Soc. 2017; 139(49):17727-17730. PMC: 5729098. DOI: 10.1021/jacs.7b10170. View

10.

Yuan S, Zuo B, Zhou S, Wang M, Tan K, Chen Z . Integrating Network Pharmacology and Experimental Validation to Explore the Pharmacological Mechanism of Astragaloside IV in Treating Bleomycin-Induced Pulmonary Fibrosis. Drug Des Devel Ther. 2023; 17:1289-1302. PMC: 10150770. DOI: 10.2147/DDDT.S404710. View

11.

Wang L, Li H, Shen X, Zeng J, Yue L, Lin J . Elucidation of the molecular mechanism of Sanguisorba Officinalis L. against leukopenia based on network pharmacology. Biomed Pharmacother. 2020; 132:110934. DOI: 10.1016/j.biopha.2020.110934. View

12.

Shah B, Davidson P, Zhong Q . Nanodispersed eugenol has improved antimicrobial activity against Escherichia coli O157:H7 and Listeria monocytogenes in bovine milk. Int J Food Microbiol. 2012; 161(1):53-9. DOI: 10.1016/j.ijfoodmicro.2012.11.020. View

13.

Islam M, Islam M, Nath N, Emran T, Rahman M, Sharma R . Recent Advances in Pyridine Scaffold: Focus on Chemistry, Synthesis, and Antibacterial Activities. Biomed Res Int. 2023; 2023:9967591. PMC: 10212683. DOI: 10.1155/2023/9967591. View

14.

Nakanishi-Matsui M, Sekiya M, Futai M . ATP synthase from Escherichia coli: Mechanism of rotational catalysis, and inhibition with the ε subunit and phytopolyphenols. Biochim Biophys Acta. 2015; 1857(2):129-140. DOI: 10.1016/j.bbabio.2015.11.005. View

15.

Rolta R, Kumar V, Sourirajan A, Upadhyay N, Dev K . Bioassay guided fractionation of rhizome extract of Rheum emodi wall as bio-availability enhancer of antibiotics against bacterial and fungal pathogens. J Ethnopharmacol. 2020; 257:112867. DOI: 10.1016/j.jep.2020.112867. View

16.

Wu H, Tu S, Zhuo Z, Jiang R, Zeng R, Yang Q . Investigating the Mechanisms of Bisdemethoxycurcumin in Ulcerative Colitis: Network Pharmacology and Experimental Verification. Molecules. 2023; 28(1). PMC: 9822216. DOI: 10.3390/molecules28010068. View

17.

Barbieri R, Coppo E, Marchese A, Daglia M, Sobarzo-Sanchez E, Nabavi S . Phytochemicals for human disease: An update on plant-derived compounds antibacterial activity. Microbiol Res. 2017; 196:44-68. DOI: 10.1016/j.micres.2016.12.003. View

18.

Cai X, Wang X, Chen Y, Wang Y, Song D, Gu Q . A natural biopreservative: Antibacterial action and mechanisms of Chinese Litsea mollis Hemsl. extract against Escherichia coli DH5α and Salmonella spp. J Dairy Sci. 2019; 102(11):9663-9673. DOI: 10.3168/jds.2019-16292. View

19.

Ahmad Z, Cox J . ATP synthase: the right size base model for nanomotors in nanomedicine. ScientificWorldJournal. 2014; 2014:567398. PMC: 3925597. DOI: 10.1155/2014/567398. View

20.

Song L, Hu X, Ren X, Liu J, Liu X . Antibacterial Modes of Herbal Flavonoids Combat Resistant Bacteria. Front Pharmacol. 2022; 13:873374. PMC: 9278433. DOI: 10.3389/fphar.2022.873374. View